BiotechTube
Home/Opthea/Jeremy M. Levin
JM

Jeremy M. Levin

Chairman of the Board

Opthea

Therapeutic Areas

Rare Disease (Pulmonary)Ophthalmology

Opthea Pipeline

DrugIndicationPhase
Sozinibercept (OPT-302)Lymphangioleiomyomatosis (LAM)Phase 2 (Planned)

Leadership Team at Opthea

KC
Kathy Connell
Non-Executive Director and Chair of Remuneration Committee
SM
Stuart Mudge
Chief Operating Officer
MG
Mike Gerometta
Chief Technology Officer
HG
Hamish George
Chief Finance Officer
View full Opthea profile